Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome vs bupivacaine hydrochloride paravertebral block for acute herpes zoster neuralgia
ChiCTR2500112433Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postherpetic neuralgia (PHN) (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Herpes Zoster Disease Burden (HZ-BOI) score (BOI-30AUC). Started Nov 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2500112433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112433.